- Investing.com
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Strategic Spin-offs | Explore DuPont's accelerated Electronics spin-off plan and the retention of its Water business, reshaping the company's structure and market focus |
Financial Resilience | Delve into DuPont's robust financial health, with strong revenue, healthy current ratio, and consistent dividend payments spanning over five decades |
Market Positioning | Learn how DuPont maintains leadership in electronics materials, water treatment, and specialty fabrics through innovation and high-value product conversion |
Future Outlook | Analyst price targets range from $84 to $105, reflecting cautious optimism amid ongoing PFAS liability concerns and potential for margin expansion |
Metrics to compare | DD | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipDDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 361.6x | −1.5x | 1.6x | |
PEG Ratio | −1.71 | −0.07 | 0.00 | |
Price/Book | 1.5x | 0.9x | 1.6x | |
Price / LTM Sales | 3.0x | 0.7x | 1.4x | |
Upside (Analyst Target) | 12.1% | −4.4% | 17.4% | |
Fair Value Upside | Unlock | 12.6% | −2.7% | Unlock |